Extraordinary Response of Metastatic Pancreatic Cancer to Chemotherapy / 대한소화기암학회지
Journal of Digestive Cancer Report
; (2): 22-25, 2019.
Article
en Ko
| WPRIM
| ID: wpr-787283
Biblioteca responsable:
WPRO
ABSTRACT
A 58-year-old woman presented with right flank and back pain for one month. After undergoing an abdominal computed tomography (CT), she was referred to our hospital. The abdominal CT showed a hypodense pancreatic tail mass with multiple retroperitoneal lymph node metastases. Positron emission tomography-computed tomography (PET-CT) scan showed high 18F-FDG uptake in pancreatic tumor and enlarged lymph nodes. Endoscopic ultrasound fine needle aspiration (EUS-FNA) revealed adenocarcinoma, which stained strongly in hENT1 (human equilibrative nucleoside transporter 1) on immunohistochemistry. She received gemcitabine 1,000 mg/m² + nanoparticle albumin-bound paclitaxel 125 mg/m² as a palliative chemotherapy. Follow-up abdominal CT and PET-CT after 4 cycles of chemotherapy showed that both pancreatic mass and the metastatic retroperitoneal lymph nodes were nearly disappeared. We report a case of 58-year-old female with metastatic pancreatic cancer who had a dramatic response to palliative chemotherapy (gemcitabine plus nanoparticle albumin-bound paclitaxel).
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Neoplasias Pancreáticas
/
Cola (estructura animal)
/
Inmunohistoquímica
/
Adenocarcinoma
/
Tomografía Computarizada por Rayos X
/
Estudios de Seguimiento
/
Ultrasonografía
/
Dolor de Espalda
/
Fluorodesoxiglucosa F18
/
Proteínas de Transporte de Nucleósidos
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Límite:
Female
/
Humans
Idioma:
Ko
Revista:
Journal of Digestive Cancer Report
Año:
2019
Tipo del documento:
Article